Fetal and maternal outcomes after maternal biologic use during
conception and pregnancy: a systematic review and meta-analysis.
Dr Laura J O’BYRNE MBBS MSc1,2, Dr Safi G ALQATARI
MBBS3, Dr Gillian M MAHER PhD 1,4,
Dr Aoife M O’SULLIVAN MB BAO BCh3, Dr Ali S KHASHAN
PhD 1,4, Dr Grainne P MURPHY MD*3,
Dr Fergus P MCCARTHY PhD *1,2
1 INFANT Research Centre, University College Cork, Cork, Ireland.
2 Department of Obstetrics and Gynaecology, Cork University Maternity
Hospital, Cork Ireland
3 Department of Rheumatology, Cork University Hospital, Cork, Ireland
4 School of Public Health, Western Gateway Building, University College
Cork, Cork, Ireland.
*Contributed equally.
Conflicts of Interest: The authors report no conflicts
of interest.
Source of Funding: This project was funded via an
education bursary awarded to Dr Grainne Murphy by UCB pharma. The funder
had no role in the design, analysis or interpretation of the research
and manuscript and had no part in the research process
following funding.
Correspondence: Laura O’Byrne, Department of Obstetrics
and Gynaecology, 5th Floor, Cork University Maternity
Hospital, Wilton, Cork, Ireland.
E-Mail: lobyrne@ucc.ie